Tisch Cancer Institute (TCI), Icahn School of Medicine — New York, New York

Tisch Cancer Institute (TCI), Icahn School of Medicine is a clinical research site located in New York, New York, United States 10029-5674.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Tisch Cancer Institute (TCI), Icahn School of Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer.

Sponsors: GI Innovation, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tisch Cancer Institute (TCI), Icahn School of Medicine?

Tisch Cancer Institute (TCI), Icahn School of Medicine has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tisch Cancer Institute (TCI), Icahn School of Medicine conducted?

Tisch Cancer Institute (TCI), Icahn School of Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer.

Is Tisch Cancer Institute (TCI), Icahn School of Medicine accredited by Crixeo Health?

Tisch Cancer Institute (TCI), Icahn School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tisch Cancer Institute (TCI), Icahn School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.